NCT04191525View on ClinicalTrials.gov

Phase II Clinical Trial to Evaluate the Efficacy and Safety of the Treatment With BPL-1 in Adult Patients With Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 10, 2018

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions

Diabetes Mellitus, Type 2

Interventions

DIETARY_SUPPLEMENT

BPL-1 Probiotic capsules

BPL-1 Probiotic 1 capsule/day

DIETARY_SUPPLEMENT

Placebo

Placebo masked with the same presentation as the experimental product 1 capsule/day

Trial Locations (1)

28006

Hospital Universitario de La princesa, Madrid

All Listed Sponsors

collaborator

Alba Garcimartín Álvarez

UNKNOWN

collaborator

Carolina Knott Torcal

UNKNOWN

collaborator

Nerea Aguirre Moreno

UNKNOWN

collaborator

Miguel Antonio Sampedro Núñez

UNKNOWN

collaborator

María Caldas

UNKNOWN

collaborator

Belén Ruiz-Rosso

UNKNOWN

collaborator

Ana María Ramos Levi

UNKNOWN

lead

Mónica Marazuela Azpíroz

OTHER

NCT04191525 - Phase II Clinical Trial to Evaluate the Efficacy and Safety of the Treatment With BPL-1 in Adult Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter